Fortis Inc FTS Q1 2026 Earnings Modest EPS Miss Amid Steady Utility Performance Marker Therapeutics Inc MRKR Q1 2026 Earnings EPS Beat Expectations Amid Development Stage Operations Eledon Pharmaceuticals Q1 2026 Earnings EPS Misses Estimates as Company Continues Clinical Pipeline Development MSGE Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher LVS Q1 2026 Earnings Strong EPS Beat Amid Macau Recovery FXNC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter